Robert Steven Kania

This inventor holds 40 USPTO granted patents and 12 published patent applications, plus 6 CIPO patents and 7 EPO patents, primarily in Kinase Inhibitors. Top assignees: Pfizer Corporation, Agouron Pharmaceuticals, Inc., Kinnate Biopharma Inc.. Active years: 2003-2025.

USPTO Granted Patents = 40 (Patent Applications = 12)

% Patents Active = 72.5

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 6.4

ph-index = 10

Forward Citations = 638(Granted Patents)

Location History:

Solana Beach, CA (US) (2018 - 2020)
San Diego, CA (US) (2003 - 2023)
Del Mar, CA (US) (2021 - 2024)

Company Filing History:

Agouron Pharmaceuticals, Inc.

patents

8 out of 14

Kinnate Biopharma Inc.

patents

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

COVID-19 Treatment

Kinase Inhibitors

Cyclin Dependent Kinase

MEK Kinase

RAF Kinase

Azalactam Compounds

Anti-Proliferative Agents

Thienopyridines

Indazole Compounds

Dihydroisoquinolinone

Macrocyclic Derivatives

Quinoline Derivatives

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12485157 - Method of Treating COVID-19 (2025-12-02),

2. 12378232 - Cyclin dependent kinase inhibitors (2025-08-05),

3. 12358897 - Compounds and method of treating COVID-19 (2025-07-15),

4. 12122800 - Inhibitors of MEK kinase (2024-10-22),

5. 11926642 - Compounds and methods for the treatment of COVID-19 (2024-03-12),

6. 11814384 - Inhibtors of Raf kinases (2023-11-14),

7. 11780862 - Inhibitors of MEK kinase (2023-10-10),

8. 11753395 - Inhibitors of MET kinase (2023-09-12),

9. 11746095 - Inhibtors of RAF kinases (2023-09-05),

10. 11684616 - Azalactam compounds as HPK1 inhibitors (2023-06-27),

11. 11407737 - Inhibitors of RAF kinases (2022-08-09),

12. 11377431 - Inhibitors of RAF kinases (2022-07-05),

13. 11345681 - Inhibitors of fibroblast growth factor receptor kinases (2022-05-31),

14. 11220494 - Cyclin dependent kinase inhibitors (2022-01-11),

15. 11203594 - Anti-proliferative agents for treating PAH (2021-12-21),

Title: The Inventor Robert Steven Kania: Revolutionizing Technology

Introduction: Robert Steven Kania, a brilliant inventor based in San Diego, CA, has been at the forefront of technological advancements for decades.

Latest Patents: Robert Steven Kania holds several groundbreaking patents in the fields of robotics, artificial intelligence, and renewable energy.

Career Highlights: With a career spanning over 30 years, Robert Steven Kania has worked with top tech companies, leading research institutions, and universities to develop cutting-edge technologies that have reshaped industries.

Collaborations: Throughout his career, Robert Steven Kania has collaborated with renowned scientists, engineers, and innovators to bring his ideas to life and create impactful solutions for complex challenges.

Conclusion: Robert Steven Kania's passion for innovation and his relentless drive to push the boundaries of technology make him a true pioneer in the world of inventions.